DG

David Lawrence Firman Gray

Pfizer: 21 patents #140 of 5,153Top 3%
Overall (All Time): #204,053 of 4,157,543Top 5%
21
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11964961 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, Michael Eric Green +6 more 2024-04-23
11014909 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, Michael Eric Green +6 more 2021-05-25
10696658 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, Michael Eric Green +6 more 2020-06-30
10421744 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, Michael Eric Green +6 more 2019-09-24
10093655 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, Michael Eric Green +6 more 2018-10-09
10077272 Heteroaromatic compounds and their use as dopamine D1 ligands Lei Zhang, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, Chewah Lee +4 more 2018-09-18
9868744 Heteroaromatic compounds and their use as dopamine D1 ligands Lei Zhang, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, Chewah Lee +4 more 2018-01-16
9856263 Heteroaromatic compounds and their use as dopamine D1 ligands Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, Scot Richard Mente, Chakrapani Subramanyam 2018-01-02
9850232 Heteroaromatic compounds and their use as dopamine D1 ligands Lei Zhang, Michael Aaron Brodney, Michael Eric Green, Chakrapani Subramanyam 2017-12-26
9822097 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, Michael Eric Green +6 more 2017-11-21
9745317 Heterocyclic compounds and their use as dopamine D1 ligands Lei Zhang, Michael Aaron Brodney, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, Michael Eric Green +2 more 2017-08-29
9688698 Heteroaromatic compounds and their use as dopamine D1 ligands Lei Zhang, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, Scot Richard Mente +1 more 2017-06-27
9617275 Heteroaromatic compounds and their use as dopamine D1 ligands Jotham Wadsworth Coe, John Arthur Allen, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov +9 more 2017-04-11
9540352 Substituted 1,7-naphthyridines as dopamine D1 ligands Lei Zhang, Michael Aaron Brodney, Michael Eric Green, Chakrapani Subramanyam 2017-01-10
9527843 Heteroaromatic compounds and their use as dopamine D1 ligands Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, Scot Richard Mente, Steven Victor O'Neil +3 more 2016-12-27
9527831 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, Michael Eric Green +6 more 2016-12-27
9139561 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, Michael Eric Green +6 more 2015-09-22
9133190 Heteroaromatic compounds and their use as dopamine D1 ligands Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, Scot Richard Mente, Steven Victor O'Neil +3 more 2015-09-15
9107923 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, Michael Eric Green +6 more 2015-08-18
8822494 Heteroaromatic compounds and their use as dopamine D1 ligands Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, Scot Richard Mente, Steven Victor O'Neil +3 more 2014-09-02
7659394 Substituted morpholine compounds for the treatment of central nervous system disorders Nancy Barta, Shelly Glase, Gregory A. Reichard, Lloyd J. Simons, Wenijan Xu 2010-02-09